GMS CLINICS AND HOSPITALS LIMITEDActive
Key figures
Like most small UK companies, GMS CLINICS AND HOSPITALS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 655,649 | 431,542 | 154,431 | 64,716 | 22,247 |
| Total assets | 658,969 | 434,052 | 154,431 | 87,114 | 69,838 |
| Total liabilities | 686,717 | 437,642 | 144,403 | 52,849 | 36,265 |
| Net assets / total equity | -27,748 | -3,590 | 10,028 | 34,265 | 33,573 |
| Average number of employees | 1 | 1 | 1 | 1 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: GMS CLINICS AND HOSPITALS LIMITED
Company
GMS CLINICS AND HOSPITALS LIMITED is a private limited company registered with Companies House under company number 06642165. It was incorporated on 9 Jul 2008. Its status is active. The registered office is in London (W1U). Its nature of business (SIC 2007) is ready-made interactive leisure and entertainment software development (62011), financial intermediation not elsewhere classified (64999), activities auxiliary to financial intermediation n.e.c. (66190), activities of collection agencies (82911).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Net assets were £33,573, down 2% on the previous year. Cash at bank and in hand was £22,247. Total assets were £69,838 and total liabilities £36,265. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 1 Nov 2026.